Jushi Holdings (JUSHF) Operating Income Growth (1y) (2022 - 2026)
Jushi Holdings (JUSHF) Operating Income Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 25.63% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | -1.30% |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | -319.32% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | -14.89% |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | 97.23% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 719.49% |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 21.25% |
| 10 | Jushi Holdings | 79.27 Mn | 39.56 Mn | 29.88 Mn | 184.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 184.61% |
| Dec 31, 2025 | 142.50% |
| Sep 30, 2025 | 1,198.89% |
| Jun 30, 2025 | -57.14% |
| Mar 31, 2025 | -145.42% |
| Dec 31, 2024 | 71.84% |
| Sep 30, 2024 | -93.63% |
| Jun 30, 2024 | 147.18% |
| Mar 31, 2024 | 264.04% |
| Dec 31, 2023 | 95.31% |
| Sep 30, 2023 | 105.60% |
| Jun 30, 2023 | 128.15% |
| Mar 31, 2023 | 86.20% |
| Dec 31, 2022 | -434.73% |
| Sep 30, 2022 | -2,667.31% |
| Jun 30, 2022 | -154.84% |